Ironwood Investment Counsel’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,872
| Closed | -$215K | – | 258 |
|
|
2024
Q3 | $215K | Buy |
+1,872
| New | +$212K | 0.04% | 245 |
|
|
2024
Q1 | – | Sell |
-2,002
| Closed | -$202K | – | 262 |
|
|
2023
Q4 | $202K | Hold |
2,002
| – | – | 0.04% | 246 |
|
|
2023
Q3 | $204K | Hold |
2,002
| – | – | 0.04% | 235 |
|
|
2023
Q2 | $202K | Buy |
+2,002
| New | +$200K | 0.05% | 208 |
|
|
2022
Q2 | – | Sell |
-2,287
| Closed | -$200K | – | 208 |
|
|
2022
Q1 | $200K | Sell |
2,287
-50
| -2% | -$4.33K | 0.05% | 207 |
|
|
2021
Q4 | $204K | Buy |
+2,337
| New | +$194K | 0.05% | 206 |
|
|
2021
Q3 | – | Sell |
-2,337
| Closed | -$213K | – | 207 |
|
|
2021
Q2 | $213K | Buy |
+2,337
| New | +$208K | 0.06% | 191 |
|
|
2021
Q1 | – | Sell |
-16,142
| Closed | -$1.52M | – | 213 |
|
|
2020
Q4 | $1.52M | Buy |
16,142
+2,380
| +17% | +$208K | 0.35% | 67 |
|
|
2020
Q3 | $1.2M | Buy |
13,762
+4,866
| +55% | +$422K | 0.32% | 72 |
|
|
2020
Q2 | $777K | Buy |
8,896
+6,178
| +227% | +$533K | 0.24% | 92 |
|
|
2020
Q1 | $224K | Buy |
2,718
+202
| +8% | +$18K | 0.09% | 150 |
|
|
2019
Q4 | $238K | Hold |
2,516
| – | – | 0.08% | 157 |
|
|
2019
Q3 | $218K | Sell |
2,516
-27
| -1% | -$2.42K | 0.08% | 161 |
|
|
2019
Q2 | $232K | Sell |
2,543
-295
| -10% | -$25K | 0.09% | 149 |
|
|
2019
Q1 | $244K | Hold |
2,838
| – | – | 0.1% | 138 |
|
|
2018
Q4 | $218K | Sell |
2,838
-708
| -20% | -$55.1K | 0.1% | 143 |
|
|
2018
Q3 | $273K | Buy |
3,546
+80
| +2% | +$5.91K | 0.11% | 128 |
|
|
2018
Q2 | $234K | Sell |
3,466
-423
| -11% | -$29.2K | 0.1% | 129 |
|
|
2018
Q1 | $281K | Buy |
3,889
+156
| +4% | +$11.9K | 0.13% | 112 |
|
|
2017
Q4 | $280K | Sell |
3,733
-614
| -14% | -$46.3K | 0.1% | 127 |
|
|
2017
Q3 | $334K | Sell |
4,347
-4,215
| -49% | -$318K | 0.14% | 111 |
|
|
2017
Q2 | $569K | Hold |
8,562
| – | – | 0.21% | 91 |
|
|
2017
Q1 | $569K | Hold |
8,562
| – | – | 0.24% | 84 |
|
|
2016
Q4 | $559K | Sell |
8,562
-814
| -9% | -$52.8K | 0.25% | 82 |
|
|
2016
Q3 | $663K | Sell |
9,376
-525
| -5% | -$38.3K | 0.31% | 75 |
|
|
2016
Q2 | $732K | Sell |
9,901
-223
| -2% | -$15.4K | 0.43% | 65 |
|
|
2016
Q1 | $657K | Hold |
10,124
| – | – | 0.34% | 70 |
|
|
2015
Q4 | $781K | Buy |
10,124
+223
| +2% | +$17.7K | 0.45% | 64 |
|
|
2015
Q3 | $815K | Sell |
9,901
-112
| -1% | -$9.97K | 0.44% | 64 |
|
|
2015
Q2 | $882K | Buy |
10,013
+1,116
| +13% | +$102K | 0.45% | 60 |
|
|
2015
Q1 | $786K | Hold |
8,897
| – | – | 0.4% | 66 |
|
|
2014
Q4 | $739K | Hold |
8,897
| – | – | 0.37% | 69 |
|
|
2014
Q3 | $750K | Sell |
8,897
-56
| -0.6% | -$4.53K | 0.4% | 65 |
|
|
2014
Q2 | $726K | Buy |
8,953
+56
| +0.6% | +$4.41K | 0.38% | 69 |
|
|
2014
Q1 | $678K | Buy |
8,897
+50
| +0.6% | +$3.64K | 0.37% | 72 |
|
|
2013
Q4 | $641K | Sell |
8,847
-2,505
| -22% | -$174K | 0.36% | 72 |
|
|
2013
Q3 | $780K | Hold |
11,352
| – | – | 0.51% | 55 |
|
|
2013
Q2 | $719K | Buy |
+11,352
| New | +$739K | 0.47% | 59 |
|
Other funds holding NVS
Ironwood Investment Counsel's NVS Position: Q4 2024 in Review
Ironwood Investment Counsel sold out of Novartis (NVS) in Q4 2024, closing a stake of 1,872 shares — an estimated $215K sold.
Ironwood Investment Counsel first reported a position in NVS in Q2 2013 and held it in 38 quarters. The position peaked at $1.52M in Q4 2020. 1,341 funds tracked by Wall St. Rank hold NVS as of Q4 2024.
- Ironwood Investment Counsel reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
- Ironwood Investment Counsel sold 1,872 Novartis shares in Q4 2024, an estimated $215K.
- Ironwood Investment Counsel first reported a position in Novartis in Q2 2013 and held it in 38 quarters.
- Ironwood Investment Counsel's Novartis position peaked at $1.52M in Q4 2020.
- 1,341 funds tracked by Wall St. Rank held Novartis as of Q4 2024.
Based on Ironwood Investment Counsel's 13F filing for Q4 2024, filed 10 Feb 2025.